SCHEMBL21907293

SCHEMBL21907293

Cc1ccc(N(c2ccccc2)c2cc3oc4cc(N(c5ccc(C)cc5)c5cccc(-c6cccc(N(c7cccc(C)c7)c7cc8oc9cc(N(c%10ccccc%10)c%10cccc(C)c%10)c%10ccccc%10c9c8c8ccccc78)c6)c5)c5ccccc5c4c3c3ccccc23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 5/20 0.33
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ MAPT P10636 4/20 0.33
▸ KDM4E B2RXH2 4/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ TP53 P04637 3/20 0.33
▸ MAOB P27338 3/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ MAPK1 P28482 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ HSD17B1 P14061 1/20 0.32
▸ HSD17B2 P37059 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ CASP3 P42574 1/20 0.32
▸ SENP8 Q96LD8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19308057 0.95 CCNC (0.34) HPGDSMN1; SMN2NPC1RAB9ATDP1
SCHEMBL15852266 0.94 HSD17B1 (0.36) HPGDSMN1; SMN2NPC1RAB9ATSHR
SCHEMBL15852271 0.93 HSD17B1 (0.35) HPGDSMN1; SMN2NPC1RAB9ATSHR
SCHEMBL15852261 0.91 TP53 (0.35) HPGDSMN1; SMN2NPC1RAB9ATSHR
SCHEMBL24859973 0.90 HPGD (0.30) HPGDSMN1; SMN2NPC1RAB9ATSHR
SCHEMBL21870235 0.90 MAPT (0.32) HPGDSMN1; SMN2NPC1RAB9ATSHR
SCHEMBL15851693 0.89 TDP1 (0.33) HPGDSMN1; SMN2NPC1RAB9ATSHR
SCHEMBL15852259 0.89 SIGMAR1 (0.35) HPGDSMN1; SMN2NPC1RAB9ATSHR
SCHEMBL15852253 0.89 TDP1 (0.36) HPGDSMN1; SMN2NPC1RAB9ATDP1
SCHEMBL21870048 0.88 MAPT (0.32) MAPTL3MBTL1HSD17B1HSD17B2CCNC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230047477-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-16 — — US disclosed
US-20230011996-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2023-01-12 — — US disclosed
US-20210384430-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-12-09 — — US disclosed
US-10804474-B2 Organic electroluminescence device and electronic apparatus provided with the same IDEMITSU KOSAN CO., LTD. (JP) 2020-10-13 — — US disclosed
US-20200111974-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2020-04-09 — — US disclosed
US-20200111962-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2020-04-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230011996-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS PROVIDED WITH THE SAME RER1, RPS19, ESR1 HPGD 3501/4885SMN1; SMN2 3301/4885NPC1 2777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback